KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance Life Science Investing
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout Medical Device Investing
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference Pharmaceutical Investing
STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026 Life Science Investing
Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September Pharmaceutical Investing
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer Life Science Investing
